Fred Alger Management’s Alpha Tau Medical DRTS Stock Holding History

Fred Alger Management’s Portfolio DRTS Stock Details DRTS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-22,481	Closed	-$131K	–	528
2022 Q3	$131K	Buy	22,481 +1,927	+9%	+$17K	﹤0.01%	430
2022 Q2	$185K	Buy	+20,554	New	+$184K	﹤0.01%	428

Other funds holding DRTS

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

STA

Summit Trail Advisors New York $6.98B AUM 19.51% 1-Year Est. Return

FGG

Financial Guidance Group Palm Harbor, Florida $249M AUM 17.15% 1-Year Est. Return

OWA

Opal Wealth Advisors Jericho, New York $463M AUM 20.47% 1-Year Est. Return

TVWM

Tower View Wealth Management Shorewood, Wisconsin $195M AUM 29.88% 1-Year Est. Return

Fred Alger Management's DRTS Position: Q4 2022 in Review

Fred Alger Management sold out of Alpha Tau Medical (DRTS) in Q4 2022, closing a stake of 22,481 shares — an estimated $131K sold.

Fred Alger Management first reported a position in DRTS in Q2 2022 and held it in 2 quarters. The position peaked at $185K in Q2 2022. 14 funds tracked by Wall St. Rank hold DRTS as of Q4 2022.

Fred Alger Management reported no remaining Alpha Tau Medical position as of Q4 2022 after selling out during the quarter.
Fred Alger Management sold 22,481 Alpha Tau Medical shares in Q4 2022, an estimated $131K.
Fred Alger Management first reported a position in Alpha Tau Medical in Q2 2022 and held it in 2 quarters.
Fred Alger Management's Alpha Tau Medical position peaked at $185K in Q2 2022.
14 funds tracked by Wall St. Rank held Alpha Tau Medical as of Q4 2022.

Based on Fred Alger Management's 13F filing for Q4 2022, filed 14 Feb 2023.